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Introduction: Soluble copper that can be acquired by bacteria is toxic and therefore antimicrobial. Whether
nanostructured copper materials, in either disperse or agglomerated form, have antimicrobial impact, aside from
that of their dissolution products, is not clear and was herein addressed.
Methods: We took five nanostructured copper materials, two metallic, and three oxo-hydroxides with one of
these being silicate-substituted. Four agglomerated in the bacterial growth media whilst the silicate-substituted
material remained disperse and small (6.5 nm diameter). Antibacterial activity against E. coli was assessed with
copper phase distribution measured over time. Using the dose of soluble copper, and benchmark dose non-linear
regression modelling, we determined how well this phase predicted antimicrobial activity. Finally, we used
Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) analysis to investigate whether membrane adhe-
sion effects by copper were plausible or if intracellular uptake most likely explained the bacterial impact of
copper.
Results: Comparison over time of antimicrobial activity against particulate or soluble phases of the aquated
materials clearly demonstrated that soluble copper but not particulate forms were associated with inhibition of
bacterial growth. Indeed, the benchmark dose modelling showed the soluble dose required to cause a 50%
reduction in E. coli growth was strongly clustered – for all particle formulations – at 14.5 mg/L (10–19 mg/L 90%
confidence interval). By comparison, total copper levels associated with the same reduction in viability varied
widely (45–549 mg/L). Finally, in favour of this soluble product dominance in terms of antimicrobial activity,
copper had low association with bacterial membrane (something both soluble and particulate materials could
do) but showed high intra-bacterial levels (something only soluble copper could do).
Conclusion: Taken together our data show that it is the uptake of soluble but not particulate copper, and the
intracellular loading not just contact and membrane association, that drives copper toxicity to bacteria.
Therapeutic strategies for novel antimicrobial copper compounds should consider these findings.
1. Introduction
Nanostructuring of materials may lead to changes in physicochem-
ical properties, beyond size differences, when compared to the bulk
material counterparts (Pfeiffer et al., 2014; Santos et al., 2018). Whilst
this can create novel applications and commercial opportunities, it has
also brought about concerns over exposure and safety for humans, other
animals and the environment (Chen et al., 2017; McClements and Xiao,
2017).
Copper has broad-spectrum antimicrobial properties (Ingle et al.,
2014; Lemire et al., 2013). This could be exploited for therapeutic
benefit but, equally, exposures could yield undesirable activity against
symbiotic bacteria in the environment, the skin or the intestine (i.e. the
microbiome). So understanding copper-bacteria interaction is
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important (Lemire et al., 2013). How much the nanostructuring of
copper-based materials governs their antimicrobial properties is not
fully understood. Certainly this nanostructuring strategy may be used to
tailor ‘slow release’ properties for copper ions or to allow stable aqu-
eous formulations of copper at high concentrations without issues with
hydrolysis and precipitation (Bastos et al., 2018; Herrmann and
Bucksch, 2015; Paulson and Kester, 1980). However, this does not ad-
dress whether particles themselves have a microbial impact beyond or
in addition to released soluble copper. On the one hand, by comparison
to silver (Xiu et al., 2012), one might assume that it is only soluble
copper, not particles, that are antimicrobial. On the other hand, in-
creased activities of copper-based nanoparticles, above and beyond just
copper ion content, have been indicated (Chen et al., 2019; Raffi et al.,
2010; Sarkar et al., 2012). Indeed, the issue of whether nanoparticles
per se have specific activity against bacteria, remains unclear but im-
portant. For example, the European Food Safety Authority (EFSA) re-
quests that, for new oral nanoparticles that are relevant to food, tests
are carried out in terms of microbiome effects for safety assessment
(EFSA, 2018).
In trying to determine whether copper-based particles, or the copper
ions that they release in an aqueous environment, are responsible for
antimicrobial activity, a number of aspects must be carefully con-
sidered. Firstly, in standard bacterial assays, total exposure to particu-
late or soluble (solubilised) copper will be determined by an interaction
between time and rates of particle dissolution. Secondly, the chemistry
of copper is complicated. At typical biological (near–neutral) pHs,
particles may form when ‘soluble’ salts are added to a solution phase,
due to oxo-hydroxide formation, polymerisation, cross-linking and
precipitation (Paulson and Kester, 1980; Zhang and Richardson, 2016).
Finally, particles, whether inadvertently formed or specifically added to
a fluid phase, may agglomerate and/or aggregate. As such, studies in-
vestigating exactly what bacteria experience in terms of exposure to
copper-based particles, and thus what chemical form is active, are
lacking (Ingle et al., 2014).
Here, we took advantage of the differential solution behaviour of
various formulations of copper-based particles and we measured their
low molecular weight (soluble), nano and agglomerated fractions over
time in bacterial culture medium alongside their antimicrobial impact
against Escherichia coli, a laboratory standard for clinically relevant
gram-negative bacteria which are increasingly associated with anti-
biotic resistant infections (Cassini et al., 2019). We then used bench-
mark dose modelling to determine the variability in effector activity of
the different phases of each particle type. Finally, we used ToF SIMS
analysis to investigate whether membrane adhesion effects by copper
were plausible, or, if intracellular uptake most likely explained the
bacterial impact of copper.
2. Materials and methods
2.1. Preparation of copper stocks
All reagents were purchased from Sigma Aldrich and used as re-
ceived, unless otherwise detailed. Copper nanopowders were purchased
from Sigma Aldrich or Alfa Aesar (Table 1). Stock solutions were pre-
pared using ultra high purity (UHP) water (reverse osmosis purification;
18.2 ΩM/cm). Dispersions of copper oxide nanoparticles (CuO NPs A)
were prepared from commercial powders (Sigma 544868) that were
reported as free of impurities and with a primary particle size of 34 nm
(Moschini et al., 2013). These have been previously investigated as
antimicrobial agents (Aruoja et al., 2009; Bastos et al., 2018). The
stocks were prepared at 20 mM copper by dispersing the powder in
water with vigorous agitation. The same protocol was repeated for
copper oxide nanoparticles Alfa Aesar 44663 (termed here as CuO NPs
B). Elemental copper nanoparticles, Sigma 774081 (termed here as
CuNPs A) and Sigma 774111 (termed here as CuNPs B), were main-
tained in an oxygen-free environment before use and were dispersed in
UHP water (20 mM copper) that had been flushed with nitrogen gas to
reduce oxygen exposure. Their purity was confirmed via Fourier
Transform – Infrared (FT-IR) spectroscopy and by determining that the
particles were 97% copper (Appendix A). Finally, silicate-stabilised
copper hydroxide nanoparticles (CuSi NPs) were synthesised by mixing
equal volumes of 400 mM sodium silicate (ca. pH 12) and 40 mM
copper chloride, which resulted in formation of blue-coloured ag-
gregates. 5 M NaOH was then added, under agitation to adjust the
suspension to pH 12 ± 0.2 and the mixture was kept under stirring
until full colloidal dispersion was observed (ca. after 24 h).
2.2. Particle characterisation in liquid suspensions
2.2.1. Particle sizing measurements
Following Initial inspection of commercial copper-based particles
dispersed in bacterial medium (Heavy Metals MOPS medium here
termed as HMM; full description in Appendix B), fast sedimentation
indicated that these were not nano-sized when suspended in aqueous
media. Therefore, static light scattering (SLS) was used to formally
determine the de facto particle size distribution of commercial copper
nanoparticles using a Mastersizer 2000 fitted with a Hydro 2000 μP
Micro Precision sample dispersion unit (Malvern Instruments Ltd., UK).
For each measurement, ca. 787 μL of each 20 mM copper stock was
added directly to the 20 mL dispersion cell unit containing HMM. The
resulting dispersion (50 mg/L copper in HMM) was run at 1000 rpm
and three consecutive measurement cycles were carried out for each
material with the settings described in Appendix C.
Dynamic Light Scattering (DLS) was used to determine the hydro-
dynamic particle size distribution by of the CuSi NPs suspension
(20 mM copper). The measurements were performed on a Zetasizer
NanoZS (Malvern Instruments Ltd., UK) using a 1 mL disposable cuvette
and a temperature of 25 ± 2 °C (n = 3). Detailed settings for the
analysis can be found in Appendix C.
2.2.2. Size categorisation in bacterial medium
To ensure that the light scatter signal from aquated microparticles,
above, was not masking a significant nano-fraction (Malvern
Instruments, 2015), we also carried out size categorisation by ultra-
filtration and centrifugation followed by elemental analysis. Copper-
based particle stocks with starting concentration of 20 mM copper were
diluted in bacterial medium – Heavy Metal MOPS medium (HMM) – to
50 mg/L (ca. 0.8 mM). Three aliquots of each stock were collected to
determine: a) the total copper content (CuTotal), b) copper in the su-
pernatant after centrifugation at 16000g for 5 min (CuSupernatant), and c)
Table 1
Properties of commercial copper nanopowders as described by suppliers.
Reference Label Composition Molecular weight Primary particle size
Sigma 544868 CuO NPs A Copper oxide (CuO) 79.545 <50 nm
10–50 nm
(Moschini et al., 2013)
Alfa Aesar 44663 CuO NPs B Copper oxide (CuO) 79.545 30–50 nm
Sigma 774081 Cu NPs A Elemental Cu (Cu0) 63.546 25 nm
Sigma 774111 Cu NPs B Elemental Cu (Cu0) 63.546 40–60 nm
C.A.P. Bastos, et al. NanoImpact 17 (2020) 100192
2
soluble copper content, after filtration with a 3KDa centrifuge filter
(Sartorius Vivaspin 500 VS0192) for 5 min at 16000 g (Cu3KDa). Fol-
lowing size differentiation, aliquots were diluted down to 20 mg/L in
5% HNO3 (v/v) or lower and kept for at least 24 h prior to analysis to
ensure full dissolution. Copper concentration was then determined by
inductively coupled plasma-optical emission spectroscopy at
324.754 nm (ICP-OES; Jobin Yvon 2000, Horiba, UK) using matrix-
matched calibration standards (0.1 to 20 mg/L). Finally, the different
fractions were calculated as per equations below:
= ×Agglomerated Cu Cu
Cu
(%) 100Total supernatant
Total
= ×Soluble Cu
Cu
(%) 100Kda
Total
3
= +Nanoparticulate Soluble(%) 100 ( (%) Agglomerated (%))
2.2.3. Soluble and particulate content in bacterial medium
20 mM coper stocks were diluted in HMM to 12.5, 25 and 50 mg/L
copper and incubated overtime at 30 °C under constant agitation
(80 rpm) in an Infors HT Minitron incubator. Samples were collected
overtime for elemental analysis as described in 2.2.2. Soluble copper
content was defined as low molecular weight copper that passed
through a 3KDa filter (Cu3kDa), whilst the remaining copper was con-
sidered particulate (CuTotal − Cu3kDa).
2.2.4. Zeta Potential Measurements
The zeta potential of copper particles stocks was determined by
Laser Doppler Micro-electrophoresis (Zetasizer NanoZS, Malvern
Instruments Ltd., UK) using disposable folded capillary cells (DTS1070)
and assuming a dielectric constant of 78.5 and a viscosity of 0.89 cP.
Cells were carefully filled with copper particle suspensions using a
syringe to avoid air bubbles, and analysis carried out as per standard
guidelines of the instrument manufacturer.
2.3. Antibacterial activity of copper materials
Antibacterial activity of copper materials was assessed using a broth
microdilution assay which is a standard approach for antimicrobial
susceptibility testing in solution (ESCMID, 2003; Reller et al., 2009).
The assays were carried out using starting bacterial loads of ca.
106 CFU/mL, which is the minimum quantifiable by optical density
(OD595nm = 0.05–0.1) allowing bacterial growth to be followed over
time and, therefore, copper effects to be assayed quantitatively. Copper
speciation and bacterial growth were followed over time. For this, Es-
cherichia coli (NCTC11100) cultures were grown in HMM (full compo-
sition in Appendix B), a defined media with low metal chelation ability
(LaRossa et al., 1995), which was supplemented with 0.4% glucose and
0.1% casein acid hydrolysate, and pH adjusted to 7.2 ± 0.2. Overnight
bacterial cultures were prepared at 30 °C in HMM under constant agi-
tation (80 rpm) in an Infors HT Minitron incubator. A turbidimetric
assay was used to follow bacterial growth over time by measuring op-
tical density (OD) at 595 nm using a Multiskan RC 351 Labsystem plate
reader. 20 mM (ca. 1.27 g/L) copper particle stocks were pre-diluted in
HMM and then mixed with E. coli suspensions that, as noted above,
were diluted to an optical density of 0.05–0.1 OD reading (ca. 106 CFU/
mL). Final copper concentrations were 0, 12.5, 25 and 50 mg/L copper.
These were chosen to be measurably toxic to bacteria whilst allowing
for observations on how variance in particulate and soluble copper
concentrations impacted growth inhibition. Bacterial cells and particles
were incubated for 8 h at 30 °C under agitation (80 rpm) and OD
measurements were obtained at different time points. Background, i.e.
OD of bacteria-free media, was subtracted for both control (OD for
media only) and for copper (OD for media plus copper material) and
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Fig. 1. Particle characterisation in stock solutions and bacterial medium. (A) Particle size distribution of commercial copper nanoparticles in bacterial medium
(HMM) at 50 mg/L copper obtained by static light scattering. (B) Particle size distribution of CuSi NPs in its original stock at 20 mM in water. (C) Copper phase
distribution of nanoparticle in bacterial medium (HMM) at 50 mg/L Cu. (D) Zeta potential of copper nanoparticles in their corresponding stocks at 20 mM copper.
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Bacterial growth inhibition over time was determined by comparing
with OD readings for copper treated against control, as per equation
below:
= ×OD Control OD Copper Treated
OD Control
Growth Inhibition% 100
2.4. Benchmark response modelling
Benchmark dose (BMD), i.e. non-linear regression analysis, was con-
ducted using the combined BMD-covariate approach described extensively
in previous work (Wills et al., 2015, 2016, 2017). Analyses were carried out
the R computing environment using the freely available PROAST package
(http://www.proast.nl). The bacterial viability dose-response data were
analysed using a nested family of four-parameter exponential models re-
commended for the analysis of continuous toxicity data by the EFSA (EFSA,
2009, 2017). In each analysis, combined dose response data for either the
total dose of copper (i.e., the dose-time product) or the released dose of
soluble copper were analysed using the factor discriminating the subgroups
(i.e., copper-based nanoparticle type) as a covariate. Models were iteratively
fitted to the data with more complex models with increasing numbers of
covariate-dependent parameters only accepted if the difference in log-like-
lihood exceeded P < 0.05. This approach allowed determination of which
model parameters needed to be estimated for each subgroup, and which
parameters could be considered constants across the combined data. Inter-
polation from the fitted model allowed estimation of the dose (i.e., the BMD)
that could be expected to cause the benchmark response (set here at a 50%
reduction in bacterial viability) for each of the particle formulations.
2.5. TOF-SIMS analysis
A 40 mM copper chloride solution was diluted to 500 mg/L (ca.
7.9 mM) in HMM and this stock was then further diluted to 12.5 mg/L
copper in an E. coli (DH5 alpha) culture in the stationary phase (pre-
cultured in Tryptic Soy Broth medium (TBS) and added in the ex-
ponential phase to HMM overnight cultures (37 °C, 200 rpm; 1.9 cm
orbit; Max 4000 Barnstead Lab-line)). Copper and bacteria were in-
cubated at room temperature for 2 h with no agitation. This culture was
subsequently centrifuged at 1500 rpm (250g; Heraeus multifuge) for
5 min and the supernatant containing the medium and free copper was
discarded. The remaining cell pellet was resuspended to the original
volume in UHP water. A sample droplet was mounted on a silicon
wafer, heat-dried, and analysed by TOF-SIMS.
ToF-SIMS imaging and depth profiling was performed using a TOF.SIMS
V (ION-TOF, GmbH) using a 25 keV bismuth liquid metal ion gun as a
primary ion source and a 10 KeV C60 ion source as a sputter source. The
delayed extraction mode was used for imaging with an approximate lateral
resolution of 400 nm at a mass resolution of approx. 3500 at m/z 58. The
pulsed primary ion current of the Bi3+ ion used was 0.2 pA. The total
primary ion dose density was 1 × 1011 ions/cm2 and therefore below the
static limit. The SurfaceLab 6 software (v. 6.6, ION-TOF GmbH) was used
for all processing of images and depth profiles. The mass spectra were ca-
librated internally to signals of [CH3]+, [C5H12N]+, and [C5H15PNO4]+.
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Fig. 2. Antimicrobial activity and phase distribution of the materials in bacterial medium.
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12.5 mg/L (top), 25 mg/L (middle) and 50 mg/L (bottom).
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Depth profiling was performed in the non-interlaced mode (2 shots
per pixel, 1 frame per sputter cycle of 1 s with a 0.5 s pause) using
C60++ ions at a current of 0.15 nA. Craters were sputtered ranging
from 150 × 150 μm2 to 300 × 300 μm2 whilst analysing areas of
50 × 50 μm2 to 150 × 150 μm2 using the primary ions. The ratio
between the analysed area and the sputtered area was>1.5. The total
C60 dose in the experiments ranged from 4.9 × 1013 ions/cm2 to
5.8 × 1014 ions/cm2.
3. Results
In the HMM bacterial medium, the commercially available nano-
particles were chiefly polydisperse micron-sized agglomerates as de-
termined by static light scattering measurements (Fig. 1A). The copper
oxides were mostly 1–10 μm in diameter and the copper metal particles
were larger (10–1000 μm). In contrast, the in-house-synthesised, sili-
cate-substituted copper oxo-hydroxides (termed CuSi NPs) had a modal
diameter of 6.5 nm and almost all were 4–20 nm in size (Fig. 1B). Size
differentiation experiments, based on filtration and centrifugation,
confirmed these findings with the aquated commercial particles domi-
nated by agglomerated material and the in-house-synthesised particles
dominated by a small nano fraction (Fig. 1C). As expected, the copper
metal particles were positively-charged in the HMM medium and the
copper oxides were negatively charged (Fig. 1D) with the aquated na-
noparticles (i.e. the CuSi NPs) showing a large enough negative zeta
potential (−27 ± 1 mV; Fig. 1D) for stable suspension in aqueous
media (Bhattacharjee, 2016).
When the particles were aquated in the E. coli-containing bacterial
medium, it was apparent that, except at the highest levels of exposure
(50 mg/L copper), the aquated nanoparticulate material had much
greater antimicrobial activity than the large particle material, during
the 8 h of experimentation (Fig. 2A). Moreover, the particulate fraction,
whether nano (CuSi NPs) or larger (other materials) or whether posi-
tively or negatively charged, appeared inversely related to bacterial
growth inhibition (Fig. 2B). Indeed, as therefore expected, the soluble
fraction of copper appeared clearly related to inhibition of E. coli
growth, over time, for all materials (Fig. 2C). Notwithstanding, the
interaction between time and solubility did not facilitate intuitive un-
derstanding of just how well soluble copper concentration might ex-
plain antimicrobial activity. To enable this, we modelled the effects on
bacterial viability over time using benchmark dose non-linear regres-
sion modelling. Firstly, we confirmed that exposure to total copper in
suspension was a very poor predictor of antimicrobial potency as would
be expected for combined soluble and particulate copper (Appendix D).
In contrast, the results for soluble copper converged across all for-
mulations tested to very similar benchmark dose levels (Fig. 3). Indeed,
when the dose required to cause a 50% reduction in E. coli viability was
compared, the total copper data showed an order of magnitude var-
iance (45–549 mg/L Cu) between particle types (Appendix D). Con-
trastingly, the dose of soluble copper required was tightly clustered for
all formulations around 14.5 mg/L with the 90% confidence interval
across all particle types spanning a range of just 10–19 mg/L (Fig. 3).
Collectively, these data strongly imply that soluble, but not particulate
copper levels whether nano or larger, achieved by hydrated copper-con-
taining particles, determine a material's antimicrobial activity. Finally,
therefore, to confirm this we considered the intracellular (i.e. intra-bacterial)
levels of copper versus that of the outer membrane following soluble copper
exposure. We reasoned that a non-contact effect would favour intracellular
copper localisation rather than membrane localisation, because the latter
could have been achieved in the studies above with particles, whereas the
former could not have been achieved with particle surfaces since bacteria
have rigid membranes and no ability to internalise particles (Santos et al.,
2018). We did not use intracellular copper sensors as we have previously
(Bastos et al., 2018; Kasemets et al., 2009) because that approach does not
enable membrane localisation to be assessed. Instead we used ToF-SIMS,
where individual bacterial cells were first identified using K+ mapping and
copper was directly analysed with a combined 63Cu + 65Cu signal
(Blockhuys et al., 2018). Following exposure to 12.5 mg/L copper, i.e. non-
precipitating conditions in the bacterial medium, the copper signal was low
at the bacterial cell membrane, the site of which was determined by
C5H15PNO4+ as before (Nygren et al., 2007), and, was high intracellularly
(Fig. 4). Collectively, our findings show that regardless of size, charge and
composition of copper-based particles, it is the release of copper ions into
solution that primarily determines their antimicrobial activity when
aquated.
4. Discussion
It is well recognised that soluble forms of copper have antibacterial
activity. However, whether particulate copper in suspension also has a
0 5 10 15 20 25 30
CuSi NPs
CuO NPs B
CuO NPs A
CuNPs B
CuNPs A
50% Growth inhibition
(Copper dose, mg.L-1.h-1)
1 0 1 9
A
B
Log10 of BMD50 : (Dose of soluble copper, mg.L-1.h-1)
L
o
g
10
B
ac
te
ri
al
G
ro
w
th
(O
D
59
5n
m
)
ra
ti
o
:
T
re
at
e
d
:U
n
tr
e
at
e
d
Fig. 3. Correlation between bacterial growth inhibition and total soluble
copper released from the particles. (A) Benchmark dose non-linear regression
modelling to compare the effect of released soluble copper on bacterial growth
inhibition. (B) 90% confidence intervals from each analysis, showing for each
particle formulation the dose required to elicit a 50% reduction in bacterial
growth. The intervals for soluble copper converge into a narrow range, unlike
for total copper that shows poor correlation across formulations, suggesting ion
release drives the inhibition effect observed.
C.A.P. Bastos, et al. NanoImpact 17 (2020) 100192
5
direct impact has not been established. Plausibility for this is posited on
the fact that copper surfaces can be used to facilitate environmental
infection control. Moreover, particles in suspension are, generally, at-
tracted to cell membranes due to entropic and, often, electrostatic
forces. Indeed, attractive forces could be enhanced using particle sur-
face coatings although these then increase particle size, which is
especially noticeable for the ultra small particle size range. On this
point, it is unlikely that bacteria acquire and internalise ultra small (or
larger) nanoparticles as the rigidity of the bacterial cell wall does not
support endocytic mechanisms (Santos et al., 2018). Particle penetra-
tion could occur if the cell membrane was degraded by a specific par-
ticle coating or carrier (e.g. surfactants), but this would not be a direct
nanoparticle interaction (Li et al., 2015; Xiu et al., 2012).
Here we show that, in the absence of a permeabilising agent, neither
large nor small particles of copper-based materials have a measurable im-
pact on bacterial growth above and beyond the effect through loss of copper
ions into the aqueous medium. In other words, it is the dissolution of
copper-based particles, but not their particulate nature per se that is re-
sponsible for the antimicrobial activity. Precisely what soluble products are
formed and at what rates this occurs, will depend upon the particle itself as
well as the nature of the aqueous environment. In the media used in this
work (HMM) there are no strong chelating agents, but the presence of
amino acids probably allows more copper in solution through weak mod-
erate interactions with the metal, than water alone would allow. In other
words, low molecular weight ligands can retard oxo-hydroxide formation of
hydrolytic metal ions (such as copper) at near-neutral pHs. However, in this
work, the same medium was used for all experiments, so conditions were
matched except for particle type. As a result, concentration of soluble
copper, over time, is the only variable that needed to be considered and its
fractionation allowed robust modelling of the phase of copper that mediated
the antimicrobial effect. Of course, we cannot exclude some effect of par-
ticulate copper-based material in terms of antimicrobial impact but this will
be negligible compared to the soluble effect.
5. Conclusion
Apart from clarifying a rather long-standing question in the field,
our findings have implications for both inadvertent and purposeful
exposures to copper-based materials. For the former, it is likely that
toxicity of copper-based materials to symbiotic bacteria is driven by
solubility in an aqueous environment. For the latter, novel copper-
based antimicrobial therapeutics should focus towards soluble rather
than nanoparticulate forms of copper as antimicrobial actives. As noted
above, nanosizing or other particulate structuring of copper materials
may have advantage for delivery and formulation purposes, but we
conclude that this is not the case for activity purposes, and, for which
dissolution is the key.
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